CID 91754520

Linperlisib

Structural Information

Molecular Formula
C28H37FN6O5S
SMILES
CC(C)(C1CCN(CC1)CC2=C3C(=CC(=C2)F)C(=NC(=N3)N4CCOCC4)C5=CC(=C(N=C5)OC)NS(=O)(=O)C)O
InChI
InChI=1S/C28H37FN6O5S/c1-28(2,36)20-5-7-34(8-6-20)17-19-13-21(29)15-22-24(31-27(32-25(19)22)35-9-11-40-12-10-35)18-14-23(33-41(4,37)38)26(39-3)30-16-18/h13-16,20,33,36H,5-12,17H2,1-4H3
InChIKey
NVWKNQGHVMMAJW-UHFFFAOYSA-N
Compound name
N-[5-[6-fluoro-8-[[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methyl]-2-morpholin-4-ylquinazolin-4-yl]-2-methoxypyridin-3-yl]methanesulfonamide
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

1
References

134
Patents

588.253 Da
Monoisotopic Mass

2.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 589.26028 238.3
[M+Na]+ 611.24222 248.4
[M+NH4]+ 606.28682 240.0
[M+K]+ 627.21616 242.7
[M-H]- 587.24572 241.5
[M+Na-2H]- 609.22767 242.1
[M]+ 588.25245 240.8
[M]- 588.25355 240.8
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe